| Financial Year |
March 31 2023 |
| Monetary Funds |
170,293,171.94 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
127,716,611.16 |
| Accounts Receivable |
128,773,927.49 |
| Advances to Suppliers |
16,192,028.21 |
| Other Receivables |
8,302,035.89 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
178,235,820.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
44,777,150.66 |
| Total Current Assets |
719,270,534.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,061,076,388.33 |
| Under-construction Projects |
50,128,273.36 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
74,262,230.15 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
79,060,801.04 |
| Deferred Income Tax Assets |
49,717,684.99 |
| Other Non-Current Assets |
22,582,573.27 |
| Sub-Total of Non-Current Assets |
1,340,273,069.46 |
| Total Assets |
2,059,543,603.71 |
| Short-Term Loans |
92,520,491.04 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
172,782,810.33 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,855,046.67 |
| Taxes Payable |
5,458,715.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
77,261,517.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
55,726,568.79 |
| Other Current Liabilities |
92,197,069.07 |
| Sub-Total of Current Liabilities |
529,186,359.22 |
| Long-term Loans |
175,087,844.21 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
178,805,327.50 |
| Total Liabilities |
707,991,686.72 |
| Paid-In Capital(Or Share Stock) |
240,000,000.00 |
| Capital Surplus |
317,565,913.25 |
| Surplus Reserve |
106,087,402.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
680,275,731.63 |
| Minority Stockholder's Interest |
6,836,226.42 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,344,715,690.57 |
| Owner's Equity（Stockholder's Equity） |
1,351,551,916.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,059,543,603.71 |
